Cargando…

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis

OBJECTIVE: Although intravenous immunoglobulin (IVIG) is the first‐line immunotherapy in autoimmune encephalitis, all supporting evidence comes from retrospective case series. Here, we performed a prospective clinical trial of IVIG for functional recovery in autoimmune encephalitis. METHODS: This si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Soon‐Tae, Lee, Han Sang, Lee, Woo‐Jin, Cha, Han‐A, Kim, Seon Hui, Shin, Seo‐Yi, Chu, Kon, Lee, Sang Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082384/ https://www.ncbi.nlm.nih.gov/pubmed/35315247 http://dx.doi.org/10.1002/acn3.51540

Ejemplares similares

Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab
por: Lee, Seolah, et al.
Publicado: (2023)

Treatment strategies for autoimmune encephalitis
por: Shin, Yong-Won, et al.
Publicado: (2017)

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin
por: Kim, Ahwon, et al.
Publicado: (2019)

Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b
por: Son, Hyoshin, et al.
Publicado: (2021)

The Laboratory Diagnosis of Autoimmune Encephalitis
por: Lee, Sang Kun, et al.
Publicado: (2016)

Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017)

Paraneoplastic encephalitis associated with renal cell carcinoma
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Proportion of peripheral regulatory T cells in patients with autoimmune encephalitis
por: Byun, Jung-Ick, et al.
Publicado: (2021)

High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Reemergence of Japanese Encephalitis in South Korea, 2010–2015
por: Sunwoo, Jun-Sang, et al.
Publicado: (2016)

Telemedicine in epilepsy and encephalitis: previous research and indication guidelines in Korea
por: Jang, Yoonhyuk, et al.
Publicado: (2022)

Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
por: Lee, Jung-Ju, et al.
Publicado: (2013)

Screening Autoimmune Anti-neuronal Antibodies in Pediatric Patients with Suspected Autoimmune Encephalitis
por: Kim, Soo Yeon, et al.
Publicado: (2014)

A Psychiatric Side Effect of Levetiracetam Can Mimic a Relapse of Anti-Leucine-Rich Glioma Inactivated 1 Encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience
por: Kinsella, JA, et al.
Publicado: (2018)

Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study
por: Byun, Jung-Ick, et al.
Publicado: (2016)

Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review
por: Wagner, Judith N., et al.
Publicado: (2021)

Postvaccinal GABA‐B receptor antibody encephalitis after ChAdOx1 nCoV‐19 vaccination
por: Ahn, Seon‐Jae, et al.
Publicado: (2022)

Anakinra treatment for refractory cerebral autoinflammatory responses
por: Jang, Yoonhyuk, et al.
Publicado: (2022)

Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews
por: Lee, Yoonkyung, et al.
Publicado: (2023)

Initial cerebrospinal fluid-restricted oligoclonal bands associate with anti-N-methyl-D-aspartate receptor encephalitis severity: a pilot study
por: Hong, Sang Bin, et al.
Publicado: (2021)

Occult Growing Teratoma as the Cause of Protracted Symptoms in a Patient with Anti-NMDA-Receptor Encephalitis and Prior Ovarian Teratoma Removal: Implications for Continued Monitoring and Treatment
por: Hong, Sang Bin, et al.
Publicado: (2021)

Anti-N-methyl-D-aspartate receptor encephalitis 8 years after serial herpes simplex virus type 1 and human herpesvirus type 7 encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination
por: Shin, Hye-Rim, et al.
Publicado: (2022)

Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy
por: Lee, Juhee, et al.
Publicado: (2022)

Prognostic Value of Initial Standard EEG and MRI in Patients with Herpes Simplex Encephalitis
por: Kim, Young-Soo, et al.
Publicado: (2016)

Disease progression and brain atrophy in NMDAR encephalitis: Associated factor & clinical implication
por: Lee, Woo‐Jin, et al.
Publicado: (2022)

Clinical significance of Epstein-Barr virus polymerase chain reaction in cerebrospinal fluid
por: Shin, Yong Woo, et al.
Publicado: (2022)

Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis
por: Shin, Yong‐Won, et al.
Publicado: (2018)

Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
por: Li, Tao-Ran, et al.
Publicado: (2020)

Opsoclonus myoclonus ataxia may differentiate postinfectious autoimmune encephalitis from infectious encephalitis
por: Lee, Seong-Joon, et al.
Publicado: (2021)

Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
por: Shimoni, Z, et al.
Publicado: (2001)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
por: Byun, Jung‐Ick, et al.
Publicado: (2019)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Korea: Clinical Features, Treatment, and Outcome
por: Lim, Jung-Ah, et al.
Publicado: (2014)

Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy
por: Ahn, Seon-Jae, et al.
Publicado: (2021)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021)

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy
por: Han, Sang Youb, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_htql529pgos6k655h524hdote4